Price T Rowe Associates Inc. MD Boosts Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)
Price T Rowe Associates Inc. MD increased its position in Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 3.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 54,753 shares of the biotechnology company’s stock after acquiring an additional 1,825 shares during […]
Price T Rowe Associates Inc. MD increased its position in Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 3.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 54,753 shares of the biotechnology company’s stock after acquiring an additional 1,825 shares during […]
